Literature DB >> 15214510

Biochemical model for inflammation of the brain: the effect of iron and transferrin on monocytes and lipid peroxidation.

Susan J van Rensburg1, Johann van Zyl, Dinie Hon, Willie Daniels, Jacobus Hendricks, Felix Potocnik, Rajiv Erasmus.   

Abstract

Cerebral inflammation plays a role in diseases such as multiple sclerosis (MS), Alzheimer's disease (AD), and depression. Iron is involved in infection and inflammation through free radical production. Theoretically transferrin should prohibit iron from participating in oxidative reactions, but transferrin has also been found to promote free radical damage. We reported previously that isolation of transferrin from plasma by ion exchange column chromatography produced a broad pink protein band that subsequently separated on a gel filtration column into three proteins containing many metals. In this study some properties of the three proteins were studied in 20 volunteers. Protein 3 (identified as transferrin by nephelometry) contained the most iron while Protein 1 (called "toxiferrin") contained significantly less iron (p < 0.00001). Plasma from volunteers obtained under conditions of infection/inflammation with fever (n = 5) had a significantly increased toxiferrin to transferrin ratio compared to healthy volunteers (n = 15; p < 0.001). In vitro, Protein 2 and transferrin inhibited lipid peroxidation, while toxiferrin (possibly a protease degradation product of transferrin), enhanced lipid peroxidation. Also, toxiferrin (1 mg/mL) caused a significant increase in viability of monocytes as measured by the 3-(4,5-dimethyl-thiazol-2-yl) 2,5-diphenyl tetrazolium bromide (MTT) reduction test, as well as the morphological transformation of monocytes to macrophages.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15214510     DOI: 10.1023/b:mebr.0000027421.33085.8b

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  36 in total

Review 1.  Phagocytes and oxidative stress.

Authors:  B M Babior
Journal:  Am J Med       Date:  2000-07       Impact factor: 4.965

2.  Newly delivered transferrin iron and oxidative cell injury.

Authors:  W Breuer; E Greenberg; Z I Cabantchik
Journal:  FEBS Lett       Date:  1997-02-17       Impact factor: 4.124

3.  Mycobacterial growth in human macrophages: variation according to donor, inoculum and bacterial strain.

Authors:  E G Hoal-van Helden; D Hon; L A Lewis; N Beyers; P D van Helden
Journal:  Cell Biol Int       Date:  2001       Impact factor: 3.612

Review 4.  Structure and spatial conformation of the iron-binding sites of transferrins.

Authors:  D Legrand; J Mazurier; J Montreuil; G Spik
Journal:  Biochimie       Date:  1988-09       Impact factor: 4.079

5.  Studies on oxidative stress, serum iron and iron binding capacity in subjects prone to the risk of coronary artery disease.

Authors:  S B Sharma; S Dwivedi; N Kumar; K M Prabhu; N Madan
Journal:  Indian Heart J       Date:  2000 Sep-Oct

6.  Inactivation of transferrin iron binding capacity by the neutrophil myeloperoxidase system.

Authors:  R A Clark; D W Pearson
Journal:  J Biol Chem       Date:  1989-06-05       Impact factor: 5.157

7.  The formation of iron-binding fragments of hen ovotransferrin by limited proteolysis.

Authors:  J Williams
Journal:  Biochem J       Date:  1974-09       Impact factor: 3.857

8.  Evidence for increased lipid peroxidation in multiple sclerosis.

Authors:  P K Toshniwal; E J Zarling
Journal:  Neurochem Res       Date:  1992-02       Impact factor: 3.996

9.  Isolation of a chymotrypsinlike enzyme from Treponema denticola.

Authors:  V J Uitto; D Grenier; E C Chan; B C McBride
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

10.  Nutritional immunity: a prospective study of thirty-three patients with acute appendicitis.

Authors:  G O Vinsant; K I Maull; H S Nelson; H E Akin; R E Pedigo
Journal:  Am Surg       Date:  1985-12       Impact factor: 0.688

View more
  9 in total

1.  Iron and the folate-vitamin B12-methylation pathway in multiple sclerosis.

Authors:  S J van Rensburg; M J Kotze; D Hon; P Haug; J Kuyler; M Hendricks; J Botha; F C V Potocnik; T Matsha; R T Erasmus
Journal:  Metab Brain Dis       Date:  2006-05-26       Impact factor: 3.584

2.  Lack of clinical manifestation of hereditary haemochromatosis in South African patients with multiple sclerosis.

Authors:  Maritha J Kotze; J Nico P de Villiers; Louise Warnich; Stephen Schmidt; Jonathan Carr; Erna Mansvelt; Elba Fourie; Susan J van Rensburg
Journal:  Metab Brain Dis       Date:  2006-07-19       Impact factor: 3.584

3.  Variations in the cerebrospinal fluid proteome following traumatic brain injury and subarachnoid hemorrhage.

Authors:  David E Connor; Ganta V Chaitanya; Prashant Chittiboina; Paul McCarthy; L Keith Scott; Lisa Schrott; Alireza Minagar; Anil Nanda; J Steven Alexander
Journal:  Pathophysiology       Date:  2017-05-13

Review 4.  The conundrum of iron in multiple sclerosis--time for an individualised approach.

Authors:  Susan J van Rensburg; Maritha J Kotze; Ronald van Toorn
Journal:  Metab Brain Dis       Date:  2012-03-17       Impact factor: 3.584

5.  Ceruloplasmin/Transferrin ratio changes in Alzheimer's disease.

Authors:  Rosanna Squitti; Carlo Salustri; Mariacristina Siotto; Mariacarla Ventriglia; Fabrizio Vernieri; Domenico Lupoi; Emanuele Cassetta; Paolo M Rossini
Journal:  Int J Alzheimers Dis       Date:  2010-12-27

6.  Magnetic resonance imaging evidence of hippocampal structural changes in patients with primary biliary cholangitis.

Authors:  Victoria A L Mosher; Mark G Swain; Jack X Q Pang; Gilaad G Kaplan; Keith A Sharkey; Glenda M MacQueen; Bradley G Goodyear
Journal:  Clin Transl Gastroenterol       Date:  2018-07-06       Impact factor: 4.488

7.  Primary biliary cholangitis patients exhibit MRI changes in structure and function of interoceptive brain regions.

Authors:  Victoria Mosher; Mark Swain; Jack Pang; Gilaad Kaplan; Keith Sharkey; Glenda MacQueen; Bradley Gordon Goodyear
Journal:  PLoS One       Date:  2019-02-08       Impact factor: 3.240

8.  Genetic variants of transferrin in cystic fibrosis.

Authors:  E Marklová; Z Albahri; H Vanícek; P Dedek; M Valis; M Kopácová; V Vávrová
Journal:  J Inherit Metab Dis       Date:  2008-02-22       Impact factor: 4.750

9.  Patient stratification in clinical glaucoma trials using the individual tear proteome.

Authors:  Janika Nättinen; Antti Jylhä; Ulla Aapola; Minna Parkkari; Alexandra Mikhailova; Roger W Beuerman; Hannu Uusitalo
Journal:  Sci Rep       Date:  2018-08-13       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.